With lambda of 0.125, 6 key factors were identified to be of great significance to the prognosis of patients with pancreatic ductal adenocarcinoma, including chemotherapy, TNM stage, diabetes, albumin, lymphocyte count and CA19-9 (Figures 1A, B). The gene discussed is ALB; the disease is pancreatic ductal adenocarcinoma.